Skip to main content

and
  1. No Access

    Article

    Primary central nervous system lymphomas associated with chronic inflammation: diagnostic pitfalls of central nervous system lymphomas

    In recent years, the features of lymphomas associated with chronic inflammation, referred to as diffuse large B-cell lymphoma (DLBCL) associated with chronic inflammation (DLBCL-CI), have been elucidated. DLBC...

    Yasuo Sugita, Jun Masuoka, Katsuharu Kameda, Kenji Takahashi in Brain Tumor Pathology (2020)

  2. No Access

    Article

    Stratification of medulloblastoma on the basis of histopathological grading

    Medulloblastoma (WHO grade IV) is an embryonal tumour of the cerebellum and the most common malignant central nervous system tumour in children. Despite significant advances in treatment, 5-year survival rates...

    Felice Giangaspero, Stefan Wellek, Jun Masuoka, Marco Gessi in Acta Neuropathologica (2006)

  3. No Access

    Article

    Capillary hemangioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin

    Capillary hemangiomas have rarely been reported to develop in the brain or spinal cord. Here we report the histological and immunohistochemical features of ten cases of central nervous system capillary hemangi...

    Masamitsu Abe, Noriyuki Misago, Shin Tanaka, Jun Masuoka in Acta Neuropathologica (2005)

  4. No Access

    Article

    Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas

    Rui M. Reis, Mitsutoshi Nakamura, Jun Masuoka, Takao Watanabe in Acta Neuropathologica (2001)

  5. No Access

    Article

    Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas

    Glioblastomas, the most malignant human brain tumors, are characterized by marked aneuploidy, suggesting chromosomal instability which may be caused by a defective mitotic spindle checkpoint. We screened 22 g...

    Rui M. Reis, Mitsutoshi Nakamura, Jun Masuoka, Takao Watanabe in Acta Neuropathologica (2001)

  6. No Access

    Article

    Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors

    Fas (APO-1/CD95) ligand (FasL) and its receptor, Fas, play a key role in the regulation of apoptosis in the immune system. FasL acts as a cytotoxic effector molecule to Fas-expressing malignant tumor cells; ho...

    Makoto Ichinose, Jun Masuoka, Tetsuya Shiraishi, Toshihiro Mineta in Brain Tumor Pathology (2001)